Page last updated: 2024-08-05 10:54:06
phenanthrenes
Any benzenoid aromatic compound that consists of a phenanthrene skeleton and its substituted derivatives thereof.
ChEBI ID: 25961
Members (25)
Member | Definition | Role |
(4R,4aS,7aR)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one | | (4R,4aS,7aR)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one |
1-(2-phenanthrenyl)ethanone | | 1-(2-phenanthrenyl)ethanone |
1-methylphenanthrene | A member of the class of phenanthrenes that is phenanthrene substituted by a methyl group at position 1. | 1-methylphenanthrene |
3-nitroperylene | | 3-Nitroperylene |
6 beta-hydroxynaltrexone | | 6alpha-Naltrexol |
7-benzylidenenaltrexone | | 7-Benzylidenenaltrexone |
7-hydroxymethyl-12-methylbenz(a)anthracene | | 7-Hydroxymethyl-12-methylbenz[a]anthracene |
7-nitrobenzanthracene | | 7-Nitrobenz[a]anthracene |
9,10-phenanthrenequinone | | 9,10-phenanthroquinone |
benz(j)aceanthrylene | | Benz[j]aceanthrylene |
benz(l)aceanthrylene | | Benz[l]aceanthrylene |
benzanthrone | | 7-benzo[a]phenalenone |
chrysene-1,4-dione | | chrysene-1,4-dione |
dibenzo(a,e)fluoranthene | | Dibenzo[a,e]fluoranthene |
dibenzo(aj)anthracene | | Dibenz[a,j]anthracene |
halofantrine | | 3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthrenyl]-1-propanol |
Hircinol | | Hircinol |
methylnaltrexone | | methylnaltrexone |
nitrobenzanthrone | | 3-Nitrobenzanthrone |
norbuprenorphine | | Norbuprenorphine |
noroxycodone | | Noroxycodone |
noroxymorphone | | Noroxymorphone |
osu 03012 | A member of the class of pyrazoles that is N-[4-(pyrazol-1-yl)phenyl]glycinamide in which the pyrazole ring is substituted at positions 3 and 5 by trifluoromethyl and phenanthrene-2-yl groups respectively. | OSU-03012 |
phenanthrene | A polycyclic aromatic hydrocarbon composed of three fused benzene rings which takes its name from the two terms 'phenyl' and 'anthracene.' | phenanthrene |
trk 820 | | nalfurafine |
Research
Studies (3,601)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
pre-1990 | 315 (8.75) | 18.7374 |
1990's | 503 (13.97) | 18.2507 |
2000's | 1,101 (30.57) | 29.6817 |
2010's | 1,384 (38.43) | 24.3611 |
2020's | 298 (8.28) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
Trials | 171 (4.47%) | 5.53% |
Reviews | 147 (3.84%) | 6.00% |
Case Studies | 83 (2.17%) | 4.05% |
Observational | 2 (0.05%) | 0.25% |
Other | 3,423 (89.47%) | 84.16% |